HIV: The Controversy of Its Evolution

  • Thread starter Thread starter Pengwuino
  • Start date Start date
Click For Summary

Discussion Overview

The discussion revolves around the evolution of HIV and the implications of a new drug, AK602, which targets the CCR5 receptor to prevent HIV from infecting immune cells. Participants explore the drug's effectiveness, safety, and potential impact on the immune system, as well as the broader context of HIV treatment and resistance.

Discussion Character

  • Exploratory
  • Technical explanation
  • Debate/contested

Main Points Raised

  • Some participants express skepticism about the safety of AK602, noting that clinical tests on 40 patients may not provide enough evidence to conclude its effectiveness or safety.
  • One participant explains the role of the CCR5 receptor in the immune response and suggests that blocking it could prevent HIV from recognizing and infecting cells, although they question how novel this approach is compared to existing treatments.
  • Another participant raises concerns about whether blocking the CCR5 receptor might leave patients vulnerable to other infections, questioning the balance between preventing HIV infection and maintaining overall immune function.

Areas of Agreement / Disagreement

Participants do not reach a consensus on the implications of the drug's mechanism or its safety. There are differing views on the novelty of the approach and the potential risks associated with interfering with the immune response.

Contextual Notes

The discussion highlights uncertainties regarding the drug's long-term effects and the complexity of the immune system's interactions with HIV and other pathogens. There is also a lack of detailed information on existing treatments that target similar mechanisms.

Biology news on Phys.org
Well, from this bit:
The researchers conducted clinical tests on 40 AIDS patients in the United States.

AK602 not only proved effective against viruses that had become resistant to other drugs, but it also caused almost no side effects, the team said.(IHT/Asahi: July 7,2005)

I'd say almost no side effects in 40 patients means it might be too soon to say how safe it really is. It'll have to go to a more extensive clinical trial to be approved, and that's when we'll find out if it really is as good as the claims.
 
CCR5 is a chemokine receptor that is expressed primarily on cells of the immune system (B-cells, T-cells, macrophages). Basically, it is important for the immune response because it helps activate the cells when there is an infection. So what I think this is about is that they found something that blocks the receptor so that HIV doesn't recognize the cell since certain strains of HIV need to recognize this receptor to infect the cell. I'm not sure how novel this idea is since I think other drugs have been made with similar functions but I don't know the specifics. Also, apparently there are other receptors that HIV can recognize although I believe this is the dominant one.

Think of it like you are trying to recognize a friend in a crowd. Normally it is easy but say we make it so all the faces are blank. Then you wouldn't be able to find your friend unless there was some other factor like a tattoo (this would be alternative receptors). Blocking the receptor is like putting HIV in a crowd of cells with no faces. It doesn't know who is who.
 
detta said:
CCR5 is a chemokine receptor that is expressed primarily on cells of the immune system (B-cells, T-cells, macrophages). Basically, it is important for the immune response because it helps activate the cells when there is an infection. So what I think this is about is that they found something that blocks the receptor so that HIV doesn't recognize the cell since certain strains of HIV need to recognize this receptor to infect the cell. I'm not sure how novel this idea is since I think other drugs have been made with similar functions but I don't know the specifics. Also, apparently there are other receptors that HIV can recognize although I believe this is the dominant one.

Thanks detta. So, does this mean the person taking this drug is still going to be vulnerable to other infections, since the drug is interferring with the normal immune response? So, it might stop the HIV from infecting cells, but then leaves them still vulnerable to all the other infections people with suppressed immune systems are vulnerable to? Or does this have a different effect?
 

Similar threads

  • · Replies 14 ·
Replies
14
Views
4K
  • · Replies 2 ·
Replies
2
Views
1K
  • · Replies 15 ·
Replies
15
Views
6K
  • · Replies 63 ·
3
Replies
63
Views
12K
Replies
10
Views
2K
  • · Replies 1 ·
Replies
1
Views
3K
  • · Replies 4 ·
Replies
4
Views
11K
  • · Replies 11 ·
Replies
11
Views
3K
Replies
32
Views
17K
  • · Replies 34 ·
2
Replies
34
Views
8K